Archives
-
Ferulic Acid, ER Stress, and Chemotherapy-Induced POI
2026-10-07
A 2026 Biomedicines study reports that ferulic acid preserves ovarian function in cyclophosphamide-induced premature ovarian insufficiency by coordinating oxidative-stress and endoplasmic-reticulum stress responses. Its central contribution is mechanistic linkage of Grp78 and the PERK/eIF2α/ATF4/CHOP pathway to granulosa-cell apoptosis, while the evidence remains preclinical and requires validation beyond mouse and KGN-cell models.
-
PGF2α/PTGFR in Endometrial Breakdown
2026-10-07
A 2024 Reproductive Sciences study identifies PGF2α signaling through PTGFR as a regulator of endometrial breakdown and vascular remodeling in a mouse menstrual-like model. Its integrated pharmacological, molecular, histological, and human-cell evidence also places HIF-1α upstream of PTGFR, while leaving important questions about human menstrual physiology and receptor specificity unresolved.
-
SR-202: Five Questions About PPARγ Evidence
2026-10-06
A source-grounded overview of what SR-202 can and cannot show about PPARγ signaling, macrophage polarization, inflammatory bowel disease, insulin resistance research, and broader metabolic applications.
-
Annexin V-PE in CD38 CAR-T Cell Death Research
2026-10-06
This overview examines how Annexin V-PE can conceptually support cell death research in CD38-directed CAR-T studies, while separating established reagent properties from findings reported in a 2026 iScience pre-proof. The CD38 study identified distinct binding and inhibition mechanisms for RP02 and 028 and reported that affinity-attenuated 028R103G CAR-T cells reduced fratricide while preserving tumor-cell cytotoxicity. However, the paper did not report using Annexin V-PE, so its relevance is inferential rather than directly validated. The article compares evidence strength, explains what phosphatidylserine externalization can and cannot show, and outlines applicability limits without providing experimental instructions.
-
ARCA EGFP mRNA (5-moUTP): Evidence Overview
2026-10-05
This overview examines ARCA EGFP mRNA (5-moUTP) as a direct fluorescent reporter for mammalian-cell studies, separating supplier-described features from published evidence on lipid nanoparticle RNA stability and identifying important limits on interpretation.
-
Vidarabine Monohydrate: Evidence and Research Context
2026-10-05
Vidarabine monohydrate, also called Spongoadenosine monohydrate, is a nucleoside analog described by the supplier as an antiviral research compound that interferes with viral DNA synthesis. This overview separates supplier-reported properties from primary-study evidence, outlines conceptual applications, and explains why a 2025 mouse study of esflurbiprofen cannot validate vidarabine or support cross-domain claims.
-
GTP Solution (100 mM): Reading mRNA Evidence
2026-10-04
GTP Solution (100 mM) is examined here as a defined molecular input within mRNA research, not as proof of therapeutic efficacy. Using the 2026 p21 mRNA–LNP bladder cancer study, this article separates nucleotide quality, transcript biology, delivery performance, and preclinical interpretation.
-
Direct Mouse Genotyping Kit Plus: Genotype to Mechanism
2026-10-03
The Direct Mouse Genotyping Kit Plus supports rapid genotype confirmation while preserving a clear boundary between allele identification and mechanistic interpretation. This article connects its analytical role with evidence from an EP4–CD36 atherosclerosis study and explains what genotyping can—and cannot—establish.
-
Substance P Workflows for NK-1 Research
2026-10-02
Build reproducible Substance P assays for NK-1 signaling, pain transmission research, and neuroimmune studies with disciplined peptide handling and staged dose design. A fluorescence-quality-control strategy inspired by pollen-interference research adds an analytical layer for detecting matrix effects without mistaking it for direct peptide quantification.
-
Obeticholic Acid Workflows for FXR Research
2026-10-01
Obeticholic Acid provides a defined FXR agonist workflow for studying bile acid regulation, cholestasis, inflammation, and fibrosis-related endpoints. This guide connects concentration-response experiments with practical histology, transcriptomics, and immune-profiling strategies inspired by recent liver fibrosis research.
-
Pyridostatin Workflows for G-Quadruplex Research
2026-10-01
Learn how to deploy Pyridostatin TFA in concentration-response, telomere, and G-quadruplex assays while preserving solvent, salt-form, and cell-line controls. The workflow also translates recent TDP-43 condensate findings into carefully bounded exploratory experiments rather than overstating evidence.
-
HAUS1–CDK4 Signaling in Hepatocellular Carcinoma
2026-09-30
This 2026 Cancer Gene Therapy study identifies HAUS1 as a transcriptional activator of CDK4 in hepatocellular carcinoma, linking an Augmin-complex subunit to malignant proliferation, invasion, and migration. Tissue analysis, cellular experiments, molecular screening, and xenograft work together to position the HAUS1–CDK4 axis as a mechanistic candidate for further HCC investigation.
-
AMG 9810 for TRPV1 Mechanism and Assay Design
2026-09-30
AMG 9810 provides a selective way to separate TRPV1-driven calcium and neuropeptide signaling from broader cellular stress responses. This guide presents practical calcium-imaging and CGRP workflows, assay controls, metabolic-stress extensions, and troubleshooting strategies for pain mechanism research.
-
Caspofungin: Designing Better Candida Assays
2026-09-29
Caspofungin is a lipopeptide antifungal drug and β-1,3-glucan synthase inhibitor with value beyond routine susceptibility testing. This article presents a mechanism-to-readout framework for Candida assays, using resistant Candida auris evidence to improve experimental interpretation.
-
Dynasore Workflows for Endocytosis Research
2026-09-29
Build reversible, time-resolved assays for dynamin-dependent cargo uptake, vesicle recycling, and implantation-related embryo studies with Dynasore. This practical guide connects concentration selection, controls, washout design, and troubleshooting to findings from a recent mouse preimplantation embryo study.